Sent:	February 6, 2018 10:50 PM
To:	rcd-dcmr
Subject:	Support for Submission of CCRM to RCC

Hello,

Recently, Treasury Board should have received a submission from the Centre for the Commercialization 
of Regenerative Medicine, as part of the Government of Canada’s call for suggestions for regulatory 
reconciliation and cooperation.

This submission affirms GE’s support for the submissions of CCRM. GE believes that regulatory 
alignment, both on environmental assessments for importation of substances for biomedical research, 
and the signing of a Mutual Recognition Agreement for GMP for adanced therapies with the United 
States, would be in the best interests of Canadian Industry, and the Canadian biomedical research 
industry.

Best regards,

 

Nicholas Kadysh
Government Affairs and Public Policy Leader
GE Global Growth